Clinical Trial Update: A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial completed comparing the safety and pharmacokinetic characteristics of CKD-337 for dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• CKD-337

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED